Evaluating latency reactivation synergies between the bromodomain inhibitor iBET-151 and the SMAC mimetic AZD5582 in SIV-infected macaques on ART by A.A. Okoye, Y. Fukazawa, B.E. Randall, R. Lum, B. Varco-Merth, S.D. Falcinelli, J. Smedley, R. Dunham, J.D. Lifson, L.J. Picker

Get full text

B cell depletion alone or in combination with IL-15 or PD-1 blockade facilitates enhanced control of virus replication in SIV-infected rhesus macaques by L.J. Picker, Y. Fukazawa, H. Behrns, B.E. Randall, B. Varco-Merth, H. Park, B.K. Felber, G.N. Pavlakis, J.D. Lifson, A.A. Okoye

Get full text

OP 2.5 – 00048 Targeting the SIV reservoir with Alemtuzumab by B. Varco-Merth, M. Chaunzwa, D. Duell, A. Marenco, S. Docken, J. Smedley, M.K. Axthelm, S.G. Hansen, M.P. Davenport, J.D. Estes, B. Keele, J.D. Lifson, S.R. Lewin, A.A. Okoye, L.J. Picker

Get full text

PP 8.1 – 00003 Optimization of the 5′ cap and untranslated regions enhances the immunogenicity of an mRNA-based therapeutic vaccine in SIV-infected rhesus macaques on ART by W. Omange, B. Varco-Merth, A. Morenco, M.T. Chaunzwa, C. Nkoy, D. Duell, O. Fadeyi, M. Medina, S. Hoffmeister, W. Goodwin, R. Butler, Z. Etaki, H. Park, J. Smedley, M.K. Axhelm, S. Hansen, J. Lifson, J. Gergen, S. Rauch, B. Petsch, L.J. Picker, A.A. Okoye

Get full text